Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gleevec and Chlorambucil in Previously Treated CLL
NCT00558961Phase 2Terminated
- Sponsor
- Jewish General Hospital
- Start
- Oct 2005
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in chronic lymphocytic leukemia (CLL), sponsored by Jewish General Hospital. Started Oct 2005; status: terminated.
02
Drugs
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00558961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00558961.